In the postmortem human AD brain, the messenger ribonucleic acid (mRNA) expressions of IGF-I and IGF-IR as well as IGF-I signaling were reduced in brain areas with high density of gray matter [3, 11–13]. Here, IGF1 is linked to Alzheimer disease.